BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11846230)

  • 1. Antigen expression during murine gamma-herpesvirus infection.
    Woodland DL; Flaño E; Usherwood EJ; Liu Luzheng ; Kim IJ; Husain SM; Sample JT; Blackman MA
    Immunobiology; 2001 Dec; 204(5):649-58. PubMed ID: 11846230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis.
    Elsawa SF; Bost KL
    J Immunol; 2004 Jan; 172(1):516-24. PubMed ID: 14688362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the host response to a gamma-herpesvirus.
    Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.
    Hu Z; Blackman MA; Kaye KM; Usherwood EJ
    J Immunol; 2015 Mar; 194(6):2746-56. PubMed ID: 25662997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis.
    Macrae AI; Usherwood EJ; Husain SM; Flaño E; Kim IJ; Woodland DL; Nash AA; Blackman MA; Sample JT; Stewart JP
    J Virol; 2003 Sep; 77(17):9700-9. PubMed ID: 12915582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for infectious mononucleosis.
    Flaño E; Woodland DL; Blackman MA
    Immunol Res; 2002; 25(3):201-17. PubMed ID: 12018460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
    Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
    J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.
    Freeman ML; Lanzer KG; Cookenham T; Peters B; Sidney J; Wu TT; Sun R; Woodland DL; Sette A; Blackman MA
    J Virol; 2010 Mar; 84(6):2881-92. PubMed ID: 20053740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murid herpesvirus-4 exploits dendritic cells to infect B cells.
    Gaspar M; May JS; Sukla S; Frederico B; Gill MB; Smith CM; Belz GT; Stevenson PG
    PLoS Pathog; 2011 Nov; 7(11):e1002346. PubMed ID: 22102809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+ T regulatory cell activity following infection.
    Gasper-Smith N; Marriott I; Bost KL
    J Immunol; 2006 Oct; 177(7):4670-8. PubMed ID: 16982906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection.
    Hardy CL; Flaño E; Cardin RD; Kim IJ; Nguyen P; King S; Woodland DL; Blackman MA
    Viral Immunol; 2001; 14(4):391-402. PubMed ID: 11792068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2.
    Cieniewicz B; Carpino N; Krug LT
    PLoS One; 2014; 9(2):e90196. PubMed ID: 24587276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononucleosis and antigen-driven T cell responses have different requirements for interleukin-2 signaling in murine gammaherpesvirus infection.
    Molloy M; Zhang W; Usherwood E
    J Virol; 2010 Oct; 84(20):10923-7. PubMed ID: 20686022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection.
    Johnson KE; Lange PT; Jondle CN; Volberding PJ; Lorenz UM; Cui W; Dittel BN; Tarakanova VL
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
    Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
    Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.
    Flaño E; Husain SM; Sample JT; Woodland DL; Blackman MA
    J Immunol; 2000 Jul; 165(2):1074-81. PubMed ID: 10878386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.
    Stevenson PG; Simas JP; Efstathiou S
    J Gen Virol; 2009 Oct; 90(Pt 10):2317-2330. PubMed ID: 19605591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.